Lisata Therapeutics Inc.
LSTA | NASDAQ
$1.56
-$0.14 (-8.24%)
At close: Sep 21, 2026, 4:00 PM ET
$1.58
+$0.02 (+1.12%)
Pre-market:
Sep 22, 2026, 8:12 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 170K | 1M | n/a | n/a | n/a | n/a |
Cost of Revenue | 146K | n/a | n/a | n/a | n/a | 63K |
Gross Profit | 24K | 1M | n/a | n/a | n/a | -63K |
Operating Income | -18.21M | -22.41M | -25.71M | -57.6M | -29.05M | -19.15M |
Interest Income | 806K | 1.88M | 2.72M | 1.05M | 151K | 132K |
Pretax Income | -17.55M | -20.78M | -23.17M | -56.7M | -28.97M | -19.01M |
Net Income | -16.59M | -19.99M | -20.84M | -54.23M | -27.47M | -8.15M |
Selling & General & Admin | 10.43M | 12.08M | 12.97M | 14.14M | 11.47M | 9.89M |
Research & Development | 7.95M | 11.33M | 12.73M | 43.46M | 17.58M | 9.25M |
Other Expenses | -146K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 18.23M | 23.41M | 25.71M | 57.6M | 29.05M | 19.15M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 18.38M | 23.41M | 25.71M | 57.6M | 29.05M | 19.15M |
Income Tax Expense | -962K | -798K | -2.33M | -2.48M | -1.51M | -10.87M |
Shares Outstanding (Basic) | 8.69M | 8.33M | 8.07M | 5.18M | 3.69M | 1.03M |
Shares Outstanding (Diluted) | 8.69M | 8.33M | 8.07M | 5.18M | 3.69M | 1.03M |
EPS (Basic) | -1.91 | -2.40 | -2.58 | -10.47 | -7.45 | -7.91 |
EPS (Diluted) | -1.91 | -2.40 | -2.58 | -10.47 | -7.45 | -7.91 |
EBITDA | -17.4M | -20.61M | -22.98M | -56.64M | -28.92M | -19.08M |
EBIT | -17.55M | -20.78M | -23.17M | -56.7M | -28.97M | -19.15M |
Depreciation & Amortization | 146K | 174K | 189K | 69K | 55K | 63K |
Add to Watchlist
Select watchlists to add or remove LSTA